Fortis Malar Hospitals Limited is a provider of super specialty and multi-specialty healthcare services. The Company focuses on providing medical care in various areas, such as Cardiology and Cardiac Surgery, Neuro Surgery, Gynecology, Orthopedics, Gastroenterology, Neurology, Pediatrics, Diabetics, Nephrology and Internal Medicine. The Company is engaged in establishing hospitals and clinics to conduct healthcare for the society in various branches of medicine, such as general surgery, pediatrics, neurology, cardiology, ears, nose and throat (ENT), ophthalmology, radiology, pathology, gastro-entrology, urology, thoracic surgery, plastic surgery, ortliapedics and other specialties to provide facilities for post graduate medical education/medical research. The Company offers its specialties in various areas, including heart care, brain and spine care, bone and joint care, digestive care and women care. The Company offers International patient care service and seniors first program.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.